Owens & Minor Q3 2024 Earnings Report

Owens & Minor EPS Results

• Actual EPS: $0.42
• Consensus EPS: $0.41
• Beat/Miss: Beat by +$0.01
• One Year Ago EPS: $0.44

Owens & Minor Revenue Results

• Actual Revenue: $2.72 billion
• Expected Revenue: $2.68 billion
• Beat/Miss: Beat by +$40.41 million
• YoY Revenue Growth: +5.00%

Owens & Minor Announcement Details

• Quarter: Q3 2024
• Date: 11/4/2024
• Time: Before Market Opens

Owens & Minor (NYSE:OMI), together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.